Related Experiment Video
Updated: May 8, 2026

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
[Changes in body composition of oncological patients receiving nutritional support]
Unlabelled:
The article is devoted to problems of diagnostic and correction of malnutrition at patients with gastric cancer, undergoing the gastroectomy.
Aims:
to study losses of body mass and dynamics of boby composition in organism of patients with gastric cancer, undergoing surgery, to estimate the efficiency of nutritional support.
Materials And Methods:
open prospective cohort case-control study. Inspected 64 patients with cancer of stomach in II-IV phases, undergoing surgery. The duration of observation amounted to 12 months. 34 of these patients were obtained nutritional support (additional enteral nutrition) during 8 weeks. The efficiency of nutritional support estimated on dynamics of body mass, body composition, the content of total protein, albumin, hemoglobin, lymphocytes counts in the blood. When statistical processing of research results the non-parametric criterion of Wilcoxon for dependent samples, as well as the dispersion rank analysis of Kraskel-Walles was used.
Conclusion:
oncological process is followed by the progression of undernutrition, independently of disease stage. The nutritional support (the additional enteral nutrition) allows to substantially to improve the nutritional status of oncological patients.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Chronic Kidney Disease III: Interprofessional Care
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Bioavailability Study Design: Healthy Subjects Versus Patients
Cancer Survival Analysis